Research graph
References from Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemia. Local targets link to admitted publications; unresolved targets remain external evidence.
Effectively leveraging RWD for external controls: a systematic literature review of regulatory and HTA decisions
10.1002/cpt.2914 · 2023 · External reference
Use of real-world evidence in postmarketing medicines regulation in the European Union: a systematic assessment of European Medicines Agency referrals 2013-2017
10.1136/bmjopen-2018-028133 · 2019 · External reference
Trial designs using real-world data: the changing landscape of the regulatory approval process
10.1002/pds.4932 · 2020 · External reference
Real-world data for regulatory decision making: challenges and possible solutions for Europe
10.1002/cpt.1426 · 2019 · External reference
Real-world evidence to inform regulatory decision making: a scoping review
10.1002/cpt.3218 · 2024 · External reference
Externally controlled studies using real-world data in patients with hematological cancers: a systematic review
10.1001/jamaoncol.2024.3466 · 2024 · External reference
Real-time data in cancer registries: validation of an automated data extraction system
10.1016/j.isci.2025.113056 · 2025 · External reference
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome
2025 · External reference
Using big data to emulate a target trial when a randomized trial is not available
10.1093/aje/kwv254 · 2016 · External reference
The central role of the propensity score in observational studies for causal effects
10.1093/biomet/70.1.41 · 1983 · External reference
An introduction to propensity score methods for reducing the effects of confounding in observational studies
10.1080/00273171.2011.568786 · 2011 · External reference
Matching methods for causal inference: a review and a look forward
10.1214/09-sts313 · 2010 · External reference
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
10.1182/blood-2016-08-733196 · 2017 · External reference
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
10.1182/blood-2005-05-2004 · 2005 · External reference
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
10.1002/pst.433 · 2011 · External reference
Sensitivity analysis in observational research: introducing the E-value
10.7326/m16-2607 · 2017 · External reference
Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients
10.1111/bjh.20185 · 2026 · External reference
Single-arm trials with historical controls: study designs to avoid time-related biases
10.1097/ede.0000000000001267 · 2021 · External reference
Enriching single-arm clinical trials with external controls: possibilities and pitfalls
10.1182/bloodadvances.2022009167 · 2023 · External reference
Implementing historical controls in oncology trials
10.1002/onco.13696 · 2021 · External reference
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia
10.1111/j.1365-2141.2006.06476.x · 2007 · External reference
Validation of the hematopoietic cell transplantation-specific comorbidity index: a prospective, multicenter GITMO study
10.1182/blood-2012-03-414573 · 2012 · External reference
The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients
10.1016/j.leukres.2011.11.021 · 2012 · External reference
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
10.3324/haematol.2012.067892 · 2013 · External reference
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
10.1182/blood-2012-12-471680 · 2013 · External reference
Accuracy of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality after intensive chemotherapy in adults with AML or other high-grade myeloid neoplasm
10.1200/jco.20.01392 · 2020 · External reference
Older patients with acute myeloid leukemia deserve individualized treatment
10.1007/s11912-022-01299-9 · 2022 · External reference
Breaking down frailty: assessing vulnerability in acute myeloid leukemia
10.1016/j.blre.2024.101224 · 2024 · External reference
Bridging the gap between RCTs and RWE through endpoint selection
10.1007/s43441-020-00193-5 · 2021 · External reference
Semiautomated pipeline to quantify tumor evolution from real-world positron emission tomography/computed tomography imaging
2023 · External reference
GENERATOR Breast DataMart—the novel breast cancer data discovery system for research and monitoring: preliminary results and future perspectives
10.3390/jpm11020065 · 2021 · External reference
Extracting data from a chemotherapy prescription platform for real-world oncology research in the UK: a pilot study
10.2217/fon-2019-0150 · 2019 · External reference
Feasibility of using real-world data to replicate clinical trial evidence
10.1001/jamanetworkopen.2019.12869 · 2019 · External reference
